Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti-Acute Myeloid Leukemia Efficacy In Vitro and In Vivo. (Record no. 30054447)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01890 a2200553 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518055531.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202003s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1521-0111 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1124/mol.119.116129 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Cao, Zhi-Xing |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200303 |
| 245 00 - TITLE STATEMENT | |
| Title | Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti-Acute Myeloid Leukemia Efficacy In Vitro and In Vivo. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Molecular pharmacology |
| Date of publication, distribution, etc. | 11 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 589-599 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Survival |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chalcones |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Enzyme Inhibitors |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glycyrrhiza |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Myeloid, Acute |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Inbred NOD |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, SCID |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Molecular Docking Simulation |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | fms-Like Tyrosine Kinase 3 |
| General subdivision | antagonists & inhibitors |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wen, Yi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | He, Jun-Lin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Huang, Shen-Zhen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gao, Fei |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guo, Chuan-Jie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Qing-Qing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zheng, Shu-Wen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gong, Dao-Yin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Yu-Zhi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhang, Ruo-Qi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chen, Jian-Ping |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Peng, Cheng |
| 773 0# - HOST ITEM ENTRY | |
| Title | Molecular pharmacology |
| Related parts | vol. 96 |
| -- | no. 5 |
| -- | p. 589-599 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1124/mol.119.116129">https://doi.org/10.1124/mol.119.116129</a> |
| Public note | Available from publisher's website |
No items available.